Aptevo Therapeutics Inc is a clinical-stage, research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidate, APVO436, and preclinical candidates, ALG.APV-527 and APVO603, were developed us... Aptevo Therapeutics Inc is a clinical-stage, research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidate, APVO436, and preclinical candidates, ALG.APV-527 and APVO603, were developed using ADAPTIR modular protein technology platform. The versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.074 | -12.5636672326 | 0.589 | 0.59 | 0.48 | 179271 | 0.52971721 | CS |
4 | -0.225 | -30.4054054054 | 0.74 | 0.89 | 0.48 | 167726 | 0.68645708 | CS |
12 | -3.415 | -86.8956743003 | 3.93 | 4.87 | 0.48 | 923993 | 1.1025871 | CS |
26 | -7.5018 | -93.5759904201 | 8.0168 | 10.8 | 0.48 | 641479 | 2.95523022 | CS |
52 | -61.085 | -99.163961039 | 61.6 | 80.96 | 0.48 | 542557 | 9.91894658 | CS |
156 | -1070.005 | -99.9518925382 | 1070.52 | 1096.48 | 0.48 | 582829 | 382.51539183 | CS |
260 | -41.285 | -98.7679425837 | 41.8 | 2640 | 0.48 | 570814 | 416.47323791 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.